#AIEye #Podcast 714: #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $PLTR) #artificialintelligence

 

 

#AIEye #Podcast 714: #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $PLTR) #artificialintelligence

 

GBT Releases New Version of Hippocrates Web App, and Palantir Announces $99.9M Contract with US Army Research Lab for AI/ML

 

Global #AI in #DrugDiscovery to Reach $4B by 2027

 

Vancouver, Kelowna, Delta, BC – July 28, 2022  – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2022/072822-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/07281GTCH-PLTR.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCH) (NYSE:PLTR)

 

GBT Technologies Inc. (OTC PINK:GTCH) has announced that it is releasing a new version of the web application for its Hippocrates machine learning driven health content provider. The new application will leverage the company’s Avant! AI engine to “provide intelligent internet search, providing answers for general or specific health related questions.” Danny Rittman, GBT’s CTO, explained:

 

"This is only one of the many possible implementations of our core Avant! AI technology. The AI system is targeted to understand a user's question, analyzing the information and providing a targeted response. Hippocrates' new release is equipped with an initial vast amount of health-related data and is situated to cognitively grow its knowledge base over time, learning from its own experiences or by training, the same way a human does. We invested vast efforts with the new release, incorporating professional, accredited data from governmental and medical documentation resources. The current release is aimed to provide a first line of health-related information. In addition, it offers Avant! intelligent internet search to provide answers and information for health-related questions. The system is not aiming to replace physicians but to provide first line health information and guidelines. We also plan to seek clinics and hospitals as partners to provide an expert assistant in specific domains, for example cardiology or pediatrics expertise.”

 

Palantir Technologies Inc. (NYSE:PLTR) has announced a two-year contract worth $99.9 million USD with the U.S. Army Research Laboratory to implement data and artificial intelligence (AI)/machine learning (ML) capabilities for users across the combatant commands (COCOMs). Akash Jain, President of Palantir USG, said:

 

"Maintaining a leading edge through technology is foundational to our mission and partnership with the Army Research Laboratory. Our nation’s armed forces require best-in-class software to fulfill their missions today while rapidly iterating on the capabilities they will need for tomorrow’s fight. We are honored to support this critical work by teaming up to deliver the most advanced operational AI capabilities available with dozens of commercial and public sector partners."

 

Global AI in Drug Discovery to Reach $4B by 2027

 

A report published by Markets and Markets finds that the global AI in Drug Discovery market is projected to grow from $600 million USD in 2022 to $4 billion by 2027, registering a compound annual growth rate (CAGR) of 45.7 percent in the forecast period. The following excerpt from the report’s description outlines the significance of Deep Learning as a driving aspect of the market:

 

Based on type, the machine learning technology segment further segmented into deep learning, supervised learning. reinforcement learning, unsupervised learning, and other machine learning technologies. Deep learning segment accounted for the largest share of the market in 2021, and this segment is also expected to grow at the highest CAGR during the forecast period. Deep learning helps in managing data in a consistent manner, saves time, reduces the chances of errors in the drug discovery process, and reduces the workload for end users are some of the key factors for the market growth of this segment.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

Disclosure: GTCH is a paid for AI featured stock on our site. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

Breaking #AI #Health #Stock News: GBT (OTCPK: $GTCH) announces a new version of Hippocrates AI Health Information System #ArtificialIntelligence

Breaking #AI #Health #Stock News: GBT (OTCPK: $GTCH) announces a new version of Hippocrates AI Health Information System #ArtificialIntelligence

 

San Diego, CA, July 28, 2022 - (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced that it is releasing a new version of its Hippocrates web application; an AI based health information system that aims to provide health information. Hippocrates is a machine learning driven health content provider that is targeted for personal and professional use. Users may provide symptoms, ask medical questions and describe conditions in order to get first line health information about possible illness, including known medication and treatments. Hippocrates new version now incorporates governmental and professional accredited data resources, among them are the CDC (Center of Dieses Control and Prevention - Centers for Disease Control and Prevention (cdc.gov), and other health resources data as references. The new release also uses Avant! AI engine to provide intelligent internet search, providing answers for general or specific health related questions. GBT is targeting Hippocrates to assist professional physicians, hospitals and clinics in specific domains to provide medical information and diagnostics assistance. The system is designed to provide ongoing training within the medical professional’s experience to gain robust knowledge over time, in addition to automatic updates of governmental resources and medical documentation. The service is also available for adults (18+) under a disclaimer and is not intended to replace a human physician. GBT plans to seek partners within the medical field including clinics or hospitals with the goal of creating a domain specific health advisory system to assist with diagnostics and recommended treatments. Hippocrates AI system is available to provide information for general health related questions via its web application at www.hmd.care.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2022/07281Hippocrates-AI-Health-Information-System.asp

 

"We are pleased to announce Hippocrates health advisory system new release, an AI driven information source for every day users" stated Danny Rittman, GBT’s CTO. "This is only one of the many possible implementations of our core Avant! AI technology. The AI system is targeted to understand a user’s question, analyzing the information and providing a targeted response. Hippocrates new release is equipped with an initial vast amount of health-related data and is situated to cognitively grow its knowledge base over time, learning from its own experiences or by training, the same way a human does. We invested vast efforts with the new release, incorporating professional, accredited data from governmental and medical documentation resources. The current release is aimed to provide a first line of health-related information. In addition, it offers Avant! intelligent internet search to provide answers and information for health-related questions. The system is not aiming to replace physicians but to provide a first line health information and guidelines. We also plan to seek clinics and hospitals as partners to provide an expert assistant in specific domains, for example cardiology or pediatrics expertise. The Hippocrates system can become a specific domain expert by professional resources ongoing training and experience. This type of system can be also useful to provide health related assistance and advising for remote locations, and for general use. Hippocrates includes mobile application synchronized with the web application making it available anywhere around the world. We plan to continue the development of the Hippocrates system, training it with more health-related information and providing it with more advanced capabilities, making it a comprehensive, personal health resource”.

 

IMPORTANT:

Hippocrates system does not provide medical advice. It is aimed for health-related informational purposes only. It doesn’t substitute professional medical advice, diagnosis or treatment. Never ignore professional medical advice or diagnostics in seeking evaluation or treatment due of material provided by Hippocrates system. If you think you may experience a medical emergency, immediately dial 911 or go to the nearest emergency room.

 

Avant! - AI set of algorithms enables GBT to potentially provide users with features and services, including statistical information, and other interactive and non-interactive features, all of which may be updated, deleted, or otherwise modified from time to time at the discretion of the GBT. The Hippocrates Platform will be provided "as is" and GBT assumes no responsibility in connection with its use and the content provided therein.

 

THE GBT AND AVANT SITES AND ANY SERVICES, CONTENT OR INFORMATION CONTAINED ON OR PROVIDED BY GBT IS PROVIDED ON AN "AS IS" BASIS. GBT DOES NOT MAKE ANY EXPRESS OR IMPLIED WARRANTIES, REPRESENTATIONS OR ENDORSEMENTS WHATSOEVER (INCLUDING WITHOUT LIMITATION WARRANTIES OF TITLE OR NONINFRINGEMENT, OR THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE) WITH REGARD TO THE SERVICE OR ANY MERCHANDISE, INFORMATION OR SERVICE PROVIDED THROUGH THE SERVICE. IN ADDITION, GBT DOES NOT GUARANTEE THAT USE OF ITS SITES WILL BE FREE FROM TECHNOLOGICAL DIFFICULTIES INCLUDING, BUT NOT LIMITED TO, UNAVAILABILITY OF INFORMATION, DOWNTIME, SERVICE DISRUPTIONS, VIRUSES OR WORMS, AND YOU UNDERSTAND THAT YOU ARE RESPONSIBLE FOR IMPLEMENTING SUFFICIENT PROCEDURES AND CHECKPOINTS TO SATISFY YOUR PARTICULAR REQUIREMENTS FOR ACCURACY OF DATA INPUT AND OUTPUT.

 

THE USE OF THE SITE IS ENTIRELY AT YOUR OWN RISK, AND IN NO EVENT SHALL GBT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY, PUNITIVE, OR ANY OTHER MONETARY OR OTHER DAMAGES, FEES, FINES, PENALTIES, OR LIABILITIES ARISING OUT OF OR RELATING IN ANY WAY TO THIS SERVICE, OR SITES ACCESSED THROUGH THIS SERVICE, AND/OR CONTENT OR INFORMATION PROVIDED HEREIN. YOUR SOLE AND EXCLUSIVE REMEDY FOR DISSATISFACTION WITH THE SERVICE IS TO STOP USING THE SERVICE. USER HEREBY ACKNOWLEDGES THAT THIS PARAGRAPH SHALL APPLY TO ALL CONTENT, MERCHANDISE AND SERVICES AVAILABLE THROUGH THE SITE.

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
GBT Technologies Inc.

Media: press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp 

 

 

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

#AIEye #Podcast 713: #Stocks discussed: (OTC: $AITX) (CSE: $PMED.C) #artificialintelligence

 

 

#AIEye #Podcast 713: #Stocks discussed: (OTC: $AITX) (CSE: $PMED.C) #artificialintelligence

 

Robotic Assistance Devices Receives New Client Order for AVA Robots, and AI-Powered Predictmedix Announces Screening Solutions Accuracy Results

 

Global #CallCenter #AI Market to Reach $8.11B by 2030

 

Vancouver, Kelowna, Delta, BC – July 25, 2022  – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence.

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2022/072522-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/07251AITX-PMED.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTC:AITX) (CSE:PMED)

 

Robotic Assistance Devices, Inc. (RAD), a wholly-owned subsidiary of Artificial Intelligence Technology Solutions Inc. (OTC:AITX), has “received an order [from a new client] for 2 AVA autonomous access control security robots from a top ranked global distribution and supply chain company with over 50 distribution centers.” RAD is described in the press release as “a high-tech start-up that delivers robotics and artificial intelligence-based solutions,” while AVA (Autonomous Verified Access), is “a compact and stanchion mountable unit that provides an edge-to-edge 180° field of vision with advanced access control over gates and other controlled points of entry.” Steve Reinharz, CEO of AITX, commented:

 

“This client is a powerhouse in moving product in and out of their facilities. I recently visited them, and the sheer magnitude of their capacity to move items is staggering. These AVA units will be a huge complement to the automation they have in place.”

 

Predictmedix Inc. (CSE:PMED), a provider of rapid health screening solutions powered by a proprietary artificial intelligence, has announced its accuracy rates for identifying respiration rate, heart rate, and core body temperature as part of its Fit for Work screening solutions. The results were respiration rate at 98.38 percent accuracy, identification of core body temperature at 98.37 percent accuracy, and the identification of heart rate at an 85 percent accuracy. Rahul Kushwah, the company’s Interim CEO, said:

 

"We are very thrilled at the phenomenal accuracy of our technology, particularly for respiration and heart rate, which are some of the hardest physiological parameters to measure. The results of the study brings not only us, but also our current clients and potential clients in our pipeline the confidence that our Fit for Work screening solutions will be a game changer for workplaces across many industries around the world.”

 

Global Call Center AI Market to Reach $8.11B by 2030

 

A report published by Verified Market Research finds that the global Call Center AI market is projected to grow from $1.35 billion USD in 2021 to $8.11 billion by 2030, registering a compound annual growth rate (CAGR) of 26.62 percent in the forecast period 2022-30. The following excerpt from the report’s description outlines the role of BFSI’s adoption of AI as a driver in the market:

 

The financial services industry (BFSI) is at the forefront of implementing AI-enabled solutions. Due to the highest adoption of AI call center platforms and solutions when compared to any other industry, the vertical is likely to lead the market for AI in call center applications throughout the forecast period. The BFSI vertical is a pioneer in the usage of AI-enabled smart chatbots, transforming the consumer experience. These chatbots interact with customers to provide an interface for automating a variety of back-end processes. AI solutions for call centers enable BFSI institutions to engage with consumers and improve their experience while also seamlessly minimizing customer turnover.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411

Get more Technology stock investor ideas - news, articles, podcasts and stock directories